AstraZeneca is buying Fusion Pharmaceuticals for $2.4 billion as the London-listed group looks to build its presence in cutting-edge cancer treatments.
AstraZeneca to buy Fusion Pharmaceuticals for up to $2.4 billion
Read Next
- 9 phrases men use when they have an above average level of emotional intelligence, says psychology
- If you want people to start genuinely enjoying your company, say goodbye to these 7 behaviors
- Senate review of Supreme Court ethics urges enforceable conduct code
- 9 signs someone isn’t actually nice, they’re a just a people-pleaser
- 6 types of family members who can be very difficult to live with, according to psychology
- If you really want to overcome your difficult childhood, say goodbye to these 7 habits
- HDFC Securities expects India GDP to moderate to 6.4% in 2024-25, ET BFSI
